Advertisement
Mayo Clinic Proceedings Home

Perception of the Risk of Stroke and the Risks and Benefits of Oral Anticoagulation for Stroke Prevention in Patients With Atrial Fibrillation: A Cross-Sectional Study

      Abstract

      Objective

      To assess the perception of the risk of stroke and the risks and benefits of oral anticoagulation (OAC) in patients with atrial fibrillation (AF).

      Patients and Methods

      Consecutive patients with chronic AF who presented for an outpatient cardiology visit or were admitted to a noncritical care cardiology ward service from September 15 through December 20, 2017, were invited to participate in this survey. Participants were asked to estimate their stroke risk without OAC and bleeding risk with OAC using a quantitative risk scale. The reported values were compared with subjectively estimated risks derived from the CHA2DS2-VASc and HAS-BLED scores. Similarly, we compared patient perception of the stroke risk reduction afforded with OAC compared with what is reported in the literature.

      Results

      A total of 227 patients were included in the analysis. The mean ± SD CHA2DS2-VASc score was 4.3±1.6, and HAS-BLED score was 2.3±1.2. Atrial fibrillation was paroxysmal in 53.3% and persistent/permanent in 46.7%. There was a negligible correlation between patient perceived and estimated risk of stroke (r=0.07; P=.32), and bleeding (r=0.16; P=.02). Most patients overestimated their risks of stroke and bleeding: 120 patients (52.9%) perceived an annual stroke risk greater than 20%, and 115 (53.5%) perceived an annual bleeding risk with OAC greater than 10%. Most patients (n=204; 89.9%) perceived that OAC would reduce their annual stroke risk by at least 50%.

      Conclusion

      Perceived risks of stroke and bleeding are markedly overestimated in most patients with AF. Further research is needed to discern the root causes and to identify effective methods of bridging this alarming disparity.

      Abbreviations:

      AF (atrial fibrillation), INR (international normalized ratio), OAC (oral anticoagulation), TIA (transient ischemic attack)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Alkhouli M.
        • Noseworthy P.A.
        • Rihal C.S.
        • Holmes Jr., D.R.
        Stroke prevention in nonvalvular atrial fibrillation: a stakeholder perspective.
        J Am Coll Cardiol. 2018; 71: 2790-2801
        • Seaburg L.
        • Hess E.P.
        • Coylewright M.
        • Ting H.H.
        • McLeod C.J.
        • Montori V.M.
        Shared decision making in atrial fibrillation: where we are and where we should be going.
        Circulation. 2014; 129: 704-710
        • Lane D.A.
        • Ponsford J.
        • Shelley A.
        • Sirpal A.
        • Lip G.Y.
        Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: effects of an educational intervention programme: the West Birmingham Atrial Fibrillation Project.
        Int J Cardiol. 2006; 110: 354-358
        • Zweiker D.
        • Zweiker R.
        • Winkler E.
        • et al.
        Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study.
        BMJ Open. 2017; 7: e018242
        • van Walraven C.
        • Hart R.G.
        • Singer D.E.
        • et al.
        Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.
        JAMA. 2002; 288: 2441-2448
        • Dentali F.
        • Riva N.
        • Crowther M.
        • Turpie A.G.
        • Lip G.Y.
        • Ageno W.
        Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.
        Circulation. 2012; 126: 2381-2391
        • Hsu J.C.
        • Maddox T.M.
        • Kennedy K.F.
        • et al.
        Oral anticoagulant therapy prescription in patients with atrial fibrillation across the spectrum of stroke risk: insights from the NCDR PINNACLE Registry.
        JAMA Cardiol. 2016; 1: 55-62
        • Yao X.
        • Abraham N.S.
        • Alexander G.C.
        • et al.
        Effect of adherence to oral anticoagulants on risk of stroke and major bleeding among patients with atrial fibrillation.
        J Am Heart Assoc. 2016; 5: e003074
        • Kaufman B.G.
        • Kim S.
        • Pieper K.
        • et al.
        Disease understanding in patients newly diagnosed with atrial fibrillation.
        Heart. 2018; 104: 494-501
        • Frankel D.S.
        • Parker S.E.
        • Rosenfeld L.E.
        • Gorelick P.B.
        HRS/NSA 2014 survey of atrial fibrillation and stroke: gaps in knowledge and perspective, opportunities for improvement.
        J Stroke Cerebrovasc Dis. 2015; 24: 1691-1700
        • Andrade J.G.
        • Krahn A.D.
        • Skanes A.C.
        • Purdham D.
        • Ciaccia A.
        • Connors S.
        Values and preferences of physicians and patients with nonvalvular atrial fibrillation who receive oral anticoagulation therapy for stroke prevention.
        Can J Cardiol. 2016; 32: 747-753
        • Perino A.C.
        • Fan J.
        • Schmitt S.K.
        • et al.
        Treating specialty and outcomes in newly Diagnosed atrial fibrillation: from the TREAT-AF Study.
        J Am Coll Cardiol. 2017; 70: 78-86
        • Rothberg M.B.
        • Scherer L.
        • Kashef M.A.
        • et al.
        The effect of information presentation on beliefs about the benefits of elective percutaneous coronary intervention.
        JAMA Intern Med. 2014; 174: 1623-1629
        • Kureshi F.
        • Jones P.G.
        • Buchanan D.M.
        • Abdallah M.S.
        • Spertus J.A.
        Variation in patients' perceptions of elective percutaneous coronary intervention in stable coronary artery disease: cross sectional study.
        BMJ. 2014; 349: g5309
        • Badin A.
        • Parr A.R.
        • Banga S.
        • Wigant R.R.
        • Baman T.S.
        Patients' and physicians' perceptions regarding the benefits of atrial fibrillation ablation.
        Pacing Clin Electrophysiol. 2017; 40: 362-371
        • Balci K.G.
        • Balci M.M.
        • Akboga M.K.
        • et al.
        Perceived benefits of implantable cardioverter defibrillator implantation among heart failure patients and its relation to quality of life: a cross-sectional study.
        Cardiol Ther. 2015; 4: 155-165

      Linked Article

      • In the Limelight: June 2019
        Mayo Clinic ProceedingsVol. 94Issue 6
        • Preview
          This monthly feature highlights five articles in the current print and online issue of Mayo Clinic Proceedings. These articles are also featured on the Mayo Clinic Proceedings' YouTube Channel ( https://youtu.be/yHIJsTUi_u0 ).
        • Full-Text
        • PDF